Hematology and oncology (Q508): United States public contracts since 2024. Since January 2024 the line carries 84 contracts worth $14,094,961 from 3 agencies. 24 suppliers share it. $5,575,334 in 2024. $5,701,267 in 2025. $2,818,361 in 2026.
Assay record ASY-US-1AYHYB50GT · Cite as: Assay Systems, “Hematology and oncology (Q508): United States public contracts since 2024”, https://assay-systems.com/register/us/line/hematology-and-oncology/
The line
Since January 2024 the line carries 84 contracts worth $14,094,961 from 3 agencies. 24 suppliers share it.
$5,575,334 in 2024. $5,701,267 in 2025. $2,818,361 in 2026.
Suppliers in the line, by value since 2024
NATIONAL MARROW DONOR PROGRAM: 13 contracts worth $2,817,440 from 1 agency since 2024.
CREATIVE TESTING SOLUTIONS: 1 contract worth $1,713,904 from 1 agency since 2024.
GREATER METROPOLITAN COMMUNITY BLOOD SERVICE, INC.: 6 contracts worth $1,577,354 from 1 agency since 2024, up 46 percent on 2022 to 2023.
LABORATORY CORPORATION OF AMERICA: 2 contracts worth $10,845 from 1 agency since 2024.
The extract for this line
Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.